A Form 4 shows Rukmini Sivaraman sold 38,139 Nutanix Class A shares at $70.002 on 17 September, leaving 325,487 shares held.
Nutanix (NTNX) disclosed a Form 4 covering transactions by reporting person Rukmini Sivaraman, who sold 38,139 Class A common shares on 17 September 2026 at $70.002 per share. The combined value of open-market transactions in the filing comes to roughly $2.67 million.
Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.
Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.
Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.
VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.
